Brica%2525252525252525252525252525252525252525252525252525252525252525252520bm

**Drug: Bric%2525252525252525252525252525252525252525252525252525252525252525252520bm** (Likely a typo, assuming "Brimonidine" or similar topical agent) ## Overview This information is based on the assumption that the drug requested is **Brimonidine**, a selective alpha-2 adrenergic agonist. Brimonidine is available in various formulations, most commonly as eye drops. ## Primary Indications * **Ophthalmic:** Reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. * **Topical (less common):** Treatment of persistent erythema associated with rosacea. ## Adult Dosing * **Ophthalmic:** * **Glaucoma/Ocular Hypertension:** Instill one drop into the affected eye(s) three times daily (approximately every 8 hours). * **Maximum Dose:** Not explicitly defined for ophthalmic use, but dosing frequency is critical. * **Topical (Rosacea):** * Apply a pea-sized amount to each area of facial redness (forehead, nose, chin, cheeks) once daily. * **Maximum Dose:** Not to exceed 1 gram daily. ## Pediatric Dosing * **Ophthalmic:** Safety and efficacy in pediatric patients have not been established. Use with caution and consider reduced systemic absorption. ## Dose Adjustments * **Hepatic/Renal Impairment:** No specific dose adjustments are typically required for ophthalmic use. Systemic absorption is generally low. For topical use in rosacea, caution is advised in severe renal impairment due to potential systemic accumulation. ## Contraindications * Hypersensitivity to brimonidine or any component of the formulation. * Use in neonates and infants (within 2 weeks of alpha-adrenergic agonist use, including brimonidine, or within 14 days of MAOI therapy). ## Adverse Effects * **Ophthalmic:** * **Common:** Ocular hyperemia, dry eye, eye irritation, foreign body sensation, conjunctival blanching, burning sensation. * **Less Common:** Blurred vision, fatigue, dizziness, headache, dry mouth, allergic reactions. * **Topical (Rosacea):** * **Common:** Erythema, flushing, skin stinging/burning, contact dermatitis. * **Less Common:** Headache, dry mouth, dizziness, dry skin. ## Key Drug Interactions * **Monoamine Oxidase Inhibitors (MAOIs):** Concomitant use is contraindicated due to potential for hypertensive crisis. * **Antihypertensives/Beta-blockers:** May have additive hypotensive effects. Monitor blood pressure. * **Central Nervous System (CNS) Depressants:** May potentiate sedative effects (e.g., alcohol, barbiturates, opioids, sedatives, anesthetics). ## Monitoring * **Ophthalmic:** * Intraocular pressure (IOP) regularly. * Signs of ocular irritation or allergy. * Systemic side effects (e.g., dizziness, drowsiness), especially in pediatric patients or those with comorbidities. * **Topical (Rosacea):** * Skin irritation or allergic reactions. * Erythema response. ## Clinical Pearls * For ophthalmic use, avoid touching the eyelid or surrounding areas with the dropper tip to prevent contamination. * If using multiple topical ophthalmic agents, instill them at least 5 minutes apart. * Systemic absorption of ophthalmic brimonidine can occur, leading to CNS depression, particularly in children. Use with caution. * For topical rosacea, skin may initially appear more red or feel warmer upon application. *** **Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and local protocols for definitive guidance. Dosing and recommendations may vary.